Verition Fund Management LLC Neogenomics Inc Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $207,834 - $274,992	15,510 New	15,510 $228,000
Q1 2024 May 14, 2024	BUY	$14.06 - $16.79 $142,990 - $170,754	10,170 New	10,170 $159,000
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $257,883 - $378,866	21,225 New	21,225 $261,000
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $202,661 - $433,637	22,295 New	22,295 $388,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $113,577 - $186,549	14,450 New	14,450 $124,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $113,334 - $224,260	-16,053 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $195,043 - $566,349	16,053 New	16,053 $195,000

283

123M

622K

72.2K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.81B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.